Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
This report studies the 10-Deacetylbaccatin III market. 10-Deacetylbaccatin III, also known as 10-DAB or 10-DAB III, is a closely related natural organic compounds isolated from dried needles and small branches of the European yew tree (Taxus baccata).10-Deacetylbaccatin III is a precursor to the anti-cancer drug docetaxel (Taxotere). pacitaxel (taxol); cabazitaxel. 10-10-deacetylbaccatin III was found to selectively inhibit the growth of L. DONOVANI intracellular amastigotes within J774 murine macrophages in vitro at nanomolar concentrations with an IC(50) value of 70 nM.
Scope of the Report:
This report focuses on the 10-Deacetylbaccatin III in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
SM Herbals
Alchem International
Indena
South Pharmaceutical
HAOXUAN
Yuannan Hande
Sai Phytoceuticals
Sarv Biolabs Pvt
Aphios
Hainan Yew Pharmaceutical
Market Segment by Countries, covering
≥95%
≥98.0%
Others
Market Segment by Type, covers
Production of Docetaxel
Production of Paclitaxel
Others
Market Segment by Applications, can be divided into
Production of Docetaxel
Production of Paclitaxel
Others
There are 15 Chapters to deeply display the North America 10-Deacetylbaccatin III market.
Chapter 1, to describe 10-Deacetylbaccatin III Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of 10-Deacetylbaccatin III, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of 10-Deacetylbaccatin III, for each country, from 2013 to 2018;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, 10-Deacetylbaccatin III market forecast, by countries, type and application, with sales, price and revenue, from 2018 to 2023;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe 10-Deacetylbaccatin III Research Findings and Conclusion, Appendix, methodology and data source
Scope of the Report:
This report focuses on the 10-Deacetylbaccatin III in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
SM Herbals
Alchem International
Indena
South Pharmaceutical
HAOXUAN
Yuannan Hande
Sai Phytoceuticals
Sarv Biolabs Pvt
Aphios
Hainan Yew Pharmaceutical
Market Segment by Countries, covering
≥95%
≥98.0%
Others
Market Segment by Type, covers
Production of Docetaxel
Production of Paclitaxel
Others
Market Segment by Applications, can be divided into
Production of Docetaxel
Production of Paclitaxel
Others
There are 15 Chapters to deeply display the North America 10-Deacetylbaccatin III market.
Chapter 1, to describe 10-Deacetylbaccatin III Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of 10-Deacetylbaccatin III, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of 10-Deacetylbaccatin III, for each country, from 2013 to 2018;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, 10-Deacetylbaccatin III market forecast, by countries, type and application, with sales, price and revenue, from 2018 to 2023;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe 10-Deacetylbaccatin III Research Findings and Conclusion, Appendix, methodology and data source
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
